Lactose India Ltd. | Small-cap | Healthcare
₹100.30
8.04%
| Lactose India Stock Comparison:
Lactose India vs Sun PharmaceuticalLactose India vs Divi's LaboratoriesLactose India vs Sun Pharma AdvancedLactose India vs Aarti DrugsLactose India vs Sequent ScientificLactose India vs NIFTY 50 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 277.7M
Gross Profit 94.6M 34.06%
Operating Income 20.2M 7.26%
Net Income 6.4M 2.31%

Balance Sheet Metrics

Total Assets 1.3B
Total Liabilities 747.3M
Shareholders Equity 587.4M
Debt to Equity 1.27

Cash Flow Metrics

Revenue & Profitability Trend

Lactose India Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i1.2B1.1B649.1M451.0M343.1M
Cost of Goods Sold i772.1M750.1M413.8M156.7M121.0M
Gross Profit i391.9M387.8M235.3M294.4M222.1M
Gross Margin % i33.7%34.1%36.2%65.3%64.7%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i-46.6M19.4M9.4M10.0M
Other Operating Expenses i98.2M45.4M29.5M32.3M30.0M
Total Operating Expenses i98.2M92.0M48.8M41.8M40.1M
Operating Income i115.7M137.9M66.9M77.3M23.8M
Operating Margin % i9.9%12.1%10.3%17.1%6.9%
Non-Operating Items
Interest Income i-3.8M3.5M2.1M1.5M
Interest Expense i61.0M52.4M59.5M51.0M54.3M
Other Non-Operating Income-----
Pre-tax Income i69.2M96.6M14.6M31.7M-32.7M
Income Tax i17.5M28.8M2.6M7.1M-7.9M
Effective Tax Rate % i25.4%29.7%17.5%22.6%0.0%
Net Income i51.6M67.9M12.1M24.5M-24.8M
Net Margin % i4.4%6.0%1.9%5.4%-7.2%
Key Metrics
EBITDA i184.1M201.1M120.7M127.3M69.7M
EPS (Basic) i-₹5.39₹0.96₹2.10₹-2.40
EPS (Diluted) i-₹5.39₹0.96₹2.10₹-2.40
Basic Shares Outstanding i-12589000125890001168392110312090
Diluted Shares Outstanding i-12589000125890001168392110312090

Income Statement Trend

Lactose India Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i44.8M15.3M5.8M19.2M21.6M
Short-term Investments i5.4M4.6M1.6M500.0K4.7M
Accounts Receivable i216.4M154.0M107.7M38.6M64.3M
Inventory i245.5M167.9M227.8M71.2M83.2M
Other Current Assets45.1M13.6M9.3M3.0K10.1M
Total Current Assets i573.3M355.3M374.0M227.5M197.0M
Non-Current Assets
Property, Plant & Equipment i522.7M12.7M12.7M12.7M12.7M
Goodwill i526.0K568.0K91.0K186.0K280.0K
Intangible Assets i-568.0K91.0K186.0K280.0K
Long-term Investments-----
Other Non-Current Assets48.3M32.5M25.1M23.9M2.0K
Total Non-Current Assets i761.4M652.1M638.9M674.7M686.4M
Total Assets i1.3B1.0B1.0B902.2M883.4M
Liabilities
Current Liabilities
Accounts Payable i106.4M83.0M182.3M40.4M21.7M
Short-term Debt i308.9M143.8M58.2M68.3M65.5M
Current Portion of Long-term Debt-----
Other Current Liabilities7.2M6.3M-2.0K-1.0K1.0K
Total Current Liabilities i448.9M254.0M264.7M149.1M116.3M
Non-Current Liabilities
Long-term Debt i259.3M248.8M326.5M344.9M395.9M
Deferred Tax Liabilities i23.2M19.0M6.8M5.8M4.6M
Other Non-Current Liabilities2.9M3.2M-2.0K--1.0K
Total Non-Current Liabilities i298.4M282.4M342.6M360.3M416.3M
Total Liabilities i747.3M536.4M607.3M509.4M532.6M
Equity
Common Stock i125.9M125.9M125.9M125.9M114.4M
Retained Earnings i-208.4M140.5M128.4M103.9M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i587.4M471.0M405.6M392.8M350.9M
Key Metrics
Total Debt i568.3M392.5M384.7M413.3M461.5M
Working Capital i124.4M101.3M109.3M78.4M80.8M

Balance Sheet Composition

Lactose India Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i69.2M96.6M14.6M31.7M-32.7M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i-169.6M7.7M-171.6M-64.8M-27.9M
Operating Cash Flow i-49.1M156.0M-97.9M16.6M-7.7M
Investing Activities
Capital Expenditures i-139.2M-21.6M-15.1M-10.3M-54.6M
Acquisitions i-----
Investment Purchases i----235.0K-8.7M
Investment Sales i---3.5M-
Investing Cash Flow i-139.2M-21.6M-15.1M-7.1M-63.3M
Financing Activities
Share Repurchases i-----
Dividends Paid i-----
Debt Issuance i-----
Debt Repayment i-----
Financing Cash Flow i65.2M66.1M-7.8M4.2M43.8M
Free Cash Flow i-146.7M65.9M63.3M71.4M-33.2M
Net Change in Cash i-123.0M200.4M-120.8M13.8M-27.1M

Cash Flow Trend

Lactose India Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 22.87
Price to Book 1.99
Price to Sales 0.92

Profitability Ratios

Profit Margin 3.47%
Operating Margin 7.82%
Return on Equity 8.79%
Return on Assets 3.87%

Financial Health

Current Ratio 1.28
Debt to Equity 96.75
Beta 0.49

Per Share Data

EPS (TTM) ₹4.06
Book Value per Share ₹46.65
Revenue per Share ₹100.50

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
lactose1.2B22.871.998.79%3.47%96.75
Sun Pharmaceutical 3.9T37.745.4315.08%19.29%3.26
Divi's Laboratories 1.6T70.8710.9114.64%23.89%0.03
Sun Pharma Advanced 47.8B-13.92-21.95157.88%-53.22%-1.24
Aarti Drugs 43.0B22.813.1412.28%7.80%44.92
Sequent Scientific 44.3B153.956.282.84%1.85%62.47

Financial data is updated regularly. All figures are in the company's reporting currency.